Pharmacotherapy of Chronic Neuropsychiatric Conditions During Pregnancy.
| Autor: | Westberg SM, Arellano R, Cieri-Hutcherson NE, Heinrich NT, Herman AM, Lodise NM, McBane S, Ofili TU, O'Grady N, Sankey KH |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Nursing for women's health [Nurs Womens Health] 2024 Jun; Vol. 28 (3), pp. 227-241. Date of Electronic Publication: 2024 May 01. |
| DOI: | 10.1016/j.nwh.2023.12.003 |
| Abstrakt: | Many pregnant persons will experience neuropsychiatric conditions during pregnancy, including migraine, attention deficit disorder, depression, and anxiety. Treatment of each of these conditions requires shared decision-making among the individual, family, and health care team. Although medications may include risk, the benefits often outweigh the potential fetal risks. In this article, we review pharmacologic treatment options for each of these conditions and appropriate use in pregnancy to maintain the stability of conditions and to optimize maternal and fetal outcomes. (Copyright © 2024 AWHONN. Published by Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|